Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome.
We report a case of left ventricular (LV) myocardial uptake of a labeled somatostatin analog in a patient with a carcinoid tumor of the small bowel. The patient developed liver metastases and a carcinoid syndrome, including right carcinoid heart disease, without right-to-left shunt on contrast ultrasonography or left ventricular myocardial metastases. The basis for visualization of the LV myocardium is probable somatostatin receptor upregulation.
Mure
A
A
Department of Nuclear Medicine, Bichat Hospital, Paris, France.
Lebtahi
R
R
Sarda
L
L
Glikmanas
M
M
Cadiot
G
G
Brochet
E
E
Faraggi
M
M
Le Guludec
D
D
D000368:Aged; D002275:Carcinoid Heart Disease / Q000000981:diagnostic imaging* / Q000378:metabolism; D002276:Carcinoid Tumor / Q000150:complications / Q000556:secondary; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006352:Heart Ventricles / Q000000981:diagnostic imaging; D006801:Humans; D007205:Indium Radioisotopes; D007414:Intestinal Neoplasms / Q000150:complications; D008113:Liver Neoplasms / Q000556:secondary; D009206:Myocardium / Q000378:metabolism; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives*; D014463:Ultrasonography; D015854:Up-Regulation
D007205:Indium Radioisotopes; D017481:Receptors, Somatostatin; D013004:Somatostatin; C081788:pentetreotide